These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2373039)

  • 41. Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
    Mauro FR; Zinzani P; Zaja F; Gentile M; Vegna ML; Stefoni V; Marin L; Fanin R; Baccarani M; Tura S; Mandelli F
    Haematologica; 2003 Dec; 88(12):1348-57. PubMed ID: 14687987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon alfa-2b in the treatment of chronic granulocytic leukemia.
    Bergsagel DE; Haas RH; Messner HA
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):29-34. PubMed ID: 3464099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b.
    Niederle N; Kloke O; May D; Becher R; Osieka R; Schmidt CG
    Invest New Drugs; 1987; 5 Suppl():S19-25. PubMed ID: 3474219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of interferon alpha-2b in advanced multiple myeloma.
    Rödjer S; Vikrot O; Wahlin A; Westin J
    J Intern Med; 1990 Jan; 227(1):45-8. PubMed ID: 2299297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-dose recombinant alfa-2a-interferon: a feasible maintenance therapy in acute myeloid leukaemia in the older patient.
    McSweeney EN; Worman CP; Tsakona CP; Jewel AP; Hoffbrand AV; Milligan DW; Burnett AK; Lewis ML; Goldstone AH
    Acta Haematol; 1993; 89(1):1-5. PubMed ID: 8480480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. alpha Interferon in the management of essential thrombocythaemia.
    Giralt M; Rubio D; Cortés MT; San Miguel J; Steegmann JL; Serena J; Fernández-Rañada JM; López-Borrasca A
    Eur J Cancer; 1991; 27 Suppl 4():S72-4. PubMed ID: 1799486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alpha interferon in the treatment of chronic myelomonocytic leukemia.
    Catalano L; Majolino I; Musto P; Fragrasso A; Molica S; Cirincione S; Selleri C; Luciano L; De Renzo A; Vecchione R
    Haematologica; 1989; 74(6):577-81. PubMed ID: 2628240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant alpha 2b interferon (alpha-2b-IFN), chlorambucil, and prednisone in advanced chronic lymphocytic leukemia (CLL).
    Mandelli F; Gastaldi R; Monarca B; Coluzzi S; De Rossi G
    Eur J Haematol; 1991 Jan; 46(1):58-9. PubMed ID: 1988312
    [No Abstract]   [Full Text] [Related]  

  • 49. [Successful treatment of adult T-cell leukemia with interferon-alpha-2b by systemic and local administration].
    Tanabe Y; An E; Futaki M; Ito T; Inokuchi K; Yamada T; Gomi S; Ohki I; Kuwabara T; Dan K
    Rinsho Ketsueki; 1990 Sep; 31(9):1572-5. PubMed ID: 2246835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of alfa-2b interferon on prognostic parameters and clinical events in HIV positive patients in the LAS/ARC stage].
    Plettenberg A; Nilsson M; Bahlmann W; Franke C; Stoehr A; Arndt R; Baumann B; Laufs R; Meigel W
    Med Klin (Munich); 1991 Nov; 86(11):555-60, 606. PubMed ID: 1685213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interferon alfa-2b in stage A untreated B-chronic lymphocytic leukaemia patients.
    Boussiotis VA; Pangalis GA
    Eur J Cancer; 1991; 27 Suppl 4():S78-9. PubMed ID: 1799487
    [No Abstract]   [Full Text] [Related]  

  • 52. Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?
    Välimäki M; Järvinen H; Salmela P; Sane T; Sjöblom SM; Pelkonen R
    Cancer; 1991 Feb; 67(3):547-9. PubMed ID: 1702352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant alpha 2-interferon in the treatment of B chronic lymphocytic leukemia in early stages.
    Rozman C; Montserrat E; Viñolas N; Urbano-Ispizua A; Ribera JM; Gallart T; Compernolle C
    Blood; 1988 May; 71(5):1295-8. PubMed ID: 3258768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transient regression in lymphocyte count in B-cell chronic lymphocytic leukemia after viral infection.
    Shirono K; Ikebe M; Inada T; Tsuda H
    Acta Haematol; 1995; 93(1):46-9. PubMed ID: 7725850
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-dose interferon-alpha in stage-I multiple myeloma and in IgM monoclonal gammopathy. Eastern Cooperative Study Group on Monoclonal Gammopathies.
    Ann Hematol; 1992 Mar; 64(3):123-7. PubMed ID: 1571407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leukaemia.
    Michieli M; Raspadori D; Damiani D; Geromin A; Gallizia C; Michelutti A; Fanin R; Fasola G; Russo D; Tazzari P
    Br J Haematol; 1991 Apr; 77(4):460-5. PubMed ID: 1673863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon alfa-2b in the treatment of chronic granulocytic leukemia.
    Bergsagel DE; Haas RH; Messner HA
    Invest New Drugs; 1987; 5 Suppl():S9-17. PubMed ID: 3298136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Peripheral neuropathy during interferon alpha therapy].
    Jaubert D; Hauteville D; Pelissier JF; Muzellec Y
    Presse Med; 1991 Feb; 20(5):221-2. PubMed ID: 1826156
    [No Abstract]   [Full Text] [Related]  

  • 59. [Modifications of immunoenzymatic aspects of B-cell chronic lymphocytic leukemia lymphocytes incubated in vitro with polyclonal B-cell activators and alpha-interferon].
    Lanza F
    Medicina (Firenze); 1988; 8(1):68-70. PubMed ID: 2465474
    [No Abstract]   [Full Text] [Related]  

  • 60. Recombinant interferon alfa-2B in refractory idiopathic immune thrombocytopenia.
    Hurtado R; Pita L; Lopez Karpovitch X; Cardenas R; Piedras J; Carrillo S; Labardini J
    Blood; 1990 Apr; 75(8):1744-6. PubMed ID: 2328325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.